BioMarin Announces The Approval and Launch of Brineura™

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the U.S. Food and Drug Administration (FDA) approved Brineura™ (cerliponase alfa) to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. Brineura is the first treatment approved to treat children with CLN2 disease, a form of Batten disease.

CLN2 disease is an ultra-rare, rapidly progressive fatal brain condition, which affects less than one in one million U.S. residents, many of whom are undiagnosed.  Every year approximately 20 children are born in the U.S. with CLN2 disease.  These affected children completely lose the ability to walk and talk around 6 years of age.  During the later stages of the disease, feeding and tending to everyday needs become very difficult with death often occurring between 8 and 12 years of age.

In clinical trials, Brineura, an enzyme replacement therapy, was shown to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with CLN2 disease. It is the first enzyme replacement therapy to be directly administered to the brain, treating the underlying cause of the condition by replacing the deficient TPP1 enzyme. Using an established technique most often used in oncology – intraventricular administration– the therapy is delivered directly into fluid surrounding the brain, known as the cerebrospinal fluid.

To support the community of families with children with neurologic disorders, BioMarin in partnership with a commercial lab is offering a no cost genetic testing program called ‘Behind the Seizure’ to support early testing for children who experience seizures.  In addition, BioMarin is investing in tools and resources to educate physicians on CLN2 disease in order to help them diagnose patients with this disease earlier and prevent them from being misdiagnosed during critical years when therapy could help slow the loss of ambulation.

In addition, BioMarin RareConnections™, a resource available to patients and families, provides a variety of personalized support services at no cost to patients, including education on CLN2 disease and Brineura, and coordination of additional services, such as information about financial assistance programs.

“We thank the FDA for recognizing Brineura’s potential to alter the course of CLN2 disease and its urgency in delivering this treatment to children as quickly and safely as possible. Brineura was approved in under four years from starting the first clinical trial to today, a significant achievement for a condition that progresses so rapidly,” said Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin. “Treating children with CLN2 disease requires an extraordinary amount of collaboration between families, hospitals, advocates and physicians. We are grateful for the partnership of all those involved and look forward to continuing to work together to make Brineura accessible to children who may benefit.”

“CNL2 is a devastating diagnosis that robs families of life with their children much too young,” said Emily de Los Reyes, M.D., attending pediatric neurologist at Nationwide Children’s Hospital and principal investigator for Brineura studies. “Today’s announcement gives my patients and their families hope.”

“The approval of Brineura is an extraordinary medical breakthrough for the CLN2 Batten community who have been waiting for this moment for more than a century when the condition was first described,” said Margie Frazier, PhD, LISW-S, Executive Director of Batten Disease Support and Research Association. “We appreciate BioMarin’s commitment and partnership to the CLN2 Batten community and investing the resources needed to bring this pivotal treatment to families.”

With this approval, the FDA also issued a Rare Pediatric Disease Priority Review Voucher, which confers priority review to a subsequent drug application that would not otherwise qualify for priority review. The rare pediatric disease review voucher program is designed to encourage development of new drugs and biologics for the prevention or treatment of rare pediatric diseases.

Brineura is expected to be available in the United States by early June, and BioMarin will begin promotion of Brineura immediately.

Last week, the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), adopted a positive opinion for the company’s Marketing Authorization Application (MAA) for Brineura to treat children with Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) disease, a form of Batten disease, which is also known as tripeptidyl peptidase 1 (TPP1) deficiency.  The CHMP’s recommendation is now referred to the European Commission (EC), which is expected to render its final decision by the second quarter of 2017.

Clinical Trial Results

The approval was supported by safety and efficacy data assessed over 96 weeks in a non-randomized, single-arm dose escalation clinical study of patients with CLN2 disease. Brineura treated patients were compared to untreated patients from a natural history cohort.

Patients were assessed for decline in the motor domain of the CLN2 Clinical Rating Scale. The scale measures performance of mobility with normal function being a score of 3 and no function being a score of 0.  Decline was defined as having a sustained 2-point decline or an unreversed score of 0 in the motor domain of the CLN2 Clinical Rating Scale.

Twenty-four patients aged 3-8 years were enrolled in the clinical study. One patient withdrew after week 1 due to inability to continue with study procedures; 23 patients were treated with Brineura every other week for 48 weeks and continued treatment during the extension.

Results from the 96-week analysis demonstrated the odds of Brineura-treated patients not having a decline were 13 times the odds of natural history cohort patients not having a decline (Odds Ratio (95% Confidence Interval): 13.1 (1.2, 146.9)).

Of the 22 patients treated with Brineura and evaluated for efficacy at week 96, 21 (95%) did not decline, and only the patient who terminated early was deemed to have a decline in the motor domain of the CLN2 Clinical Rating Scale. In comparison, 50% of patients in an independent natural history cohort demonstrated progressive decline in motor function.  Two Brineura treated patients with a maximum score were excluded from the analyses; they maintained that score throughout the study period.

In the clinical study, intraventricular access device-related infections were observed in two patients. In each case, antibiotics were administered, the intraventricular access device was replaced and the patient continued on Brineura treatment.  Hypotension was reported in 2 (8%) patients, which occurred during or up to 8 hours after Brineura infusion. Patients did not require alteration in treatment and reactions resolved spontaneously or after IV fluid administration.

Hypersensitivity reactions have been reported in 11 (46%) Brineura treated patients during the clinical studies.  The most common adverse reactions (≥8%) are pyrexia, ECG abnormalities, decreased cerebrospinal fluid (CSF) protein, vomiting, seizures, hypersensitivity, increased CSF protein, hematoma, headache, irritability, pleocytosis, device-related infection, bradycardia, feeling jittery, and hypotension.

About CLN2 Disease

Children with CLN2 disease typically begin experiencing seizures between the ages of 2 and 4 years old, preceded in the majority of cases by language development delay.  The disease progresses rapidly with most affected children losing the ability to walk and talk by approximately 6 years of age.  Initial symptoms are followed by movement disorders, motor deterioration, dementia, blindness, and death usually occurring between the ages of 8 and 12 years of age.  During the later stages of the disease, feeding and tending to everyday needs become very difficult. BioMarin estimates the incidence of CLN2 disease is approximately one in 200,000 with up to 1,200 to 1,600 children in the regions of the world where BioMarin operates, many of whom are undiagnosed.

The neuronal ceroid lipofuscinoses (NCLs) are a heterogeneous group of lysosomal storage disorders that includes the autosomal recessive neurodegenerative disorder CLN2 disease. CLN2 disease is caused by mutations in the TPP1 gene resulting in deficient activity of the enzyme tripeptidyl peptidase 1 (TPP1). In the absence of TPP1, lysosomal storage materials normally metabolized by this enzyme accumulate in many organs, particularly in the brain and retina. Buildup of these storage materials in the cells of the nervous system contribute to the progressive and relentless neurodegeneration which manifests as loss of cognitive, motor, and visual functions.

North Bay Leadership Council’s 2017 State of the North Bay Conference

The North Bay is enjoying its best economic times in years, but employers can expect ongoing trouble finding workers as baby boomers retire and millennials leave the region so they can afford to buy homes.

That was the message business leaders gave Wednesday morning to the North Bay Leadership Council, a collection of employers who promote economic development. The event drew about 150 business, civic and elected leaders to the Sheraton Hotel in Petaluma.

Keynote speaker Micah Weinberg, president of the Bay Area Council Economic Institute, a regional think tank, said the North Bay is enjoying “the top of the market” in terms of the current economic cycle. The region is basically at full employment, because those who remain without jobs generally lack the skills needed for the positions businesses are seeking to fill.

But the region’s tech sector didn’t get a boost from the robust growth that came to San Francisco and Silicon Valley. Instead, tech jobs in Sonoma County have declined 22 percent since 2000, a drop others have attributed to the dot-com bust and the exodus of tech jobs overseas.

Also, he said, the high cost of housing has made it difficult for many residents around the state to make ends meet.

“California has the highest rate of poverty in the nation” when adjusted for cost of living, Weinberg said. Housing costs are so high in Marin County that a family of four with an annual income of $105,350 qualifies as low income under federal criteria.

Over the next seven years, the state predicts the North Bay sectors with the most employment growth will be office and administrative support and food preparation and serving-related occupations.

Weinberg said those sectors generally offer lower-paying positions and he suggested business leaders may want to spur job growth in tech and other higher-paying sectors.

He also noted a survey released this spring by the Bay Area Council, a business development group that supports his institute, which found nearly half of Bay Area millennials are thinking of leaving the region. Those younger adults, ages 18-39, still want a house of their own, Weinberg said, and too often they find “there are no single-family homes to move into in the Bay Area.”

In a subsequent panel of business leaders, Jim Geist, a regional vice president for the staffing firm Nelson & Associates, said finding workers today is “brutal” for employers.

Those seeking skilled workers “have to take them from another employer,” he said. For example, businesses seeking an accountant now making $60,000 a year may have to offer $70,000.

Another speaker, Hamish Gray, a senior vice president for Santa Rosa’s Keysight Technologies, said the test and measurement company will have hundreds of workers retiring here in the coming years.

Keysight will find new engineers to replace those that retire, he said. But replacing technicians will be difficult, because they will become increasingly in demand as more electronic products require someone skilled to install, maintain or repair them.

“We will all be competing for the same people,” Gray said.

Arrow Benefits Group Allocates $100,000 for Donation to Place Life-Saving AED Machines in Businesses Throughout Community

Arrow Benefits Group has allocated an unprecedented $100,000 in order to place AED (Automated External Defibrillator) machines with employers throughout the local community over the course of the next five years. This builds on its Arrow Wellness Initiative, which was established two years ago to offer free CPR and first-aid classes to its clients and the community.

“The Arrow Wellness Initiative has been utilized by businesses since its inception, and it was always our goal to build on this program,” said Arrow Benefits Group Principal Andrew McNeil. “Our clients see value in implementing employee benefits that go beyond the norm and that improve health and cost outcomes, as well as performance in the workplace. We are dedicated to helping our clients take proactive actions to keep their employees healthy and safe.”

Arrow’s funds will be donated to clients who wish to purchase AED machines for their business location. To help implement its CPR and first-aid training, as well as AED installation, maintenance and registration, Arrow has partnered with the Petaluma Health Care District’s HeartSafe Community initiative and Healthquest training center.

“HeartSafe Community was established to strengthen the community’s ability to respond to a cardiac emergency,” said Ramona Faith, CEO of the Petaluma Health Care District. “Arrow was one of our first HeartSafe Businesses and is pioneering how companies should be approaching wellness in the workplace. With regard to heart health in particular, businesses are on the front lines with cardiac response because cardiac arrest is the leading cause of death in the workplace. Arrow understands this and is doing amazing work in our community. Its pledge to buy AEDs for businesses throughout the region is unparalleled.”

Access to AED machines significantly increases the chance of survival in the event of sudden cardiac arrest, which is the leading cause of death within the workplace, claiming 10,000 lives each year. Immediate CPR and AED deployment within three-five minutes of collapse increases sudden cardiac arrest survival rates as much as 70%; without intervention, survival rates average 7%. The dramatic difference in survival rates with the addition of an AED device is what motivated Arrow to donate $100,000 and partner with North Bay employers to place these machines within workplaces throughout the region. By coupling the District’s HeartSafe Community initiative and Arrow’s donation, McNeil hopes to improve safety within the workplace, and, by extension, within the community. He adds, “We believe we can build a stronger community by building stronger employers. Stronger employers translate into a stronger local economy and happier, more productive citizens.”

“Arrow is the first company in our area to make this kind of a donation for AED machines,” said Stacy Gibbons, executive director of American Heart Association in the North Bay. “There are not enough in our community, and the contribution will not only help get them placed with employers, but it will save lives. The AED is critical to the survival of someone who has suffered a cardiac arrest – 10,000 Americans die on the job from cardiac arrest each year.”

For more information on the program contact Andrew McNeil 707-992-3789 or

About Arrow Benefits Group

Arrow Benefits Group, the third largest benefits firm in the North Bay, is a proud partner of United Benefit Advisors (UBA), one of the largest benefits consulting and brokerage firms in the country.

Arrow Benefits Group is the single-source solution for managing the complexities of benefits with expert advice, customized programs, and personalized solutions. Arrow’s innovative programs control costs and give employees a greater sense of financial and emotional security. For straight answers to employee benefits call 707-992-3780 or visit

FALCK Northern California Achieves Profession’s Highest Honor

After two years of work, Falck Northern California has been awarded accreditation by the Commission on the Accreditation of Ambulance Services. This achievement places FNC in the top 1% of all ambulance services in the nation.
“Our team has worked long and hard on this project and we are very proud of what this means for Falck. Our accreditation places us head and shoulders above most ambulance providers in the US.” said Gary Tennyson, CEO of Falck Northern California.
Falck Northern California has a workforce of over 500 employees and provides 911, Critical Care, and interfacility transport services and is permitted in twenty-nine counties across Northern California.

Congratulations to all of our Members Chosen to be the North Bay Business Journal’s 2017 Women in Business Honorees

How the winners are chosen

The nominations include those submitted by our readers, previous honorees and our editorial department.

The achievements and contributions of the nominees made the selection process difficult. Undoubtedly, many of this year’s nominees will be named winners in the future.

Winners were chosen based on many factors, including leadership roles in the organization, business-related innovations, vision and community involvement.



  • Kristina Derkos, senior vice president of administration, Redwood Credit Union, Santa Rosa
  • Denise Dutra Maloney, director of business development, The Dutra Group, San Rafael
  • Katie Evans, vice president of operations, La Tortilla Factory, Santa Rosa
  • Judy Sakaki, Ph.D., president, Sonoma State University, Rohnert Park
  • Julie Silk, environmental compliance program manager, Keysight Technologies, Santa Rosa
  • Regina Sullivan, M.D., MBA, CPE, medical director, maternal child health, obstetrics/gynecology, Kaiser Permanente Santa Rosa Medical Center, Santa Rosa
  • Robin Wenzel, senior vice president and senior relationship manager, Wells Fargo Bank, North Coast Regional Commercial Banking, Santa Rosa

Redwood Credit Union Ranks Among Nation’s Top Performers

Redwood Credit Union (RCU) has recently been ranked a top performer in the country by multiple sources, including top five healthiest credit unions by Glatt Consulting, the sixth best performing credit union in the nation by S&P Global Market Intelligence, and one of the top business lenders in volume by BauerFinancial, Inc.

Glatt Consulting, an independent firm that studies the financial health of credit unions, has ranked Redwood Credit Union among the top five healthiest credit unions (of nearly 6,000) nationwide. Glatt uses 17 performance metrics to calculate its Credit Union HealthScore, including financial and operational strength and growth, asset quality, asset/liability management, and productivity. RCU is the only credit union to have been ranked in the top five in each of the last three years.

S&P Global Market Intelligence ranked Redwood Credit Union 6th best performing credit union in the nation based on 2016 metrics. The ranking was based on member growth, market growth, operating expenses, net charge-offs, and delinquent loans as a percentage of total loans.

BauerFinancial, Inc., an independent organization who reports and analyzes the performance of U.S. credit unions and banks, rated Redwood Credit Union a five-star institution for financial strength—their highest designation. They also recognized the credit union’s business loan growth to be exceptionally strong and ranked among the most prolific in the nation.

“Financial strength and stability is critical for any financial institution, and as a credit union, our continued growth allows us to return even greater value to our Members and community, and further help them succeed,” says Brett Martinez, president & CEO. 

About Redwood Credit Union

Founded in 1950, Redwood Credit Union is a full-service financial institution providing personal and business banking to consumers and businesses in the North Bay and San Francisco. RCU offers complete financial services including checking and savings accounts, auto and home loans, credit cards, online and mobile banking, business services, commercial and SBA lending, investment and financial planning services, and more. The Credit Union also offers insurance and discount auto sales through their wholly-owned subsidiary. RCU has over $3.5 billion in assets and serves over 285,000 Members with full-service branches from San Francisco to Ukiah, more than 30,000 fee-free network ATMs nationwide plus a foreign ATM fee rebate program, and convenient, free online and mobile banking. RCU can be followed on Facebook at and on Twitter at @redwoodcu. For more information, please call 

1 (800) 479-7928 or visit  

The Buck Institute for Research on Aging’s Impact Circle Picks its 2017 Project

When given the option of research projects to support, Buck Impact Circle members recently pooled their resources and chose to invest $120,000 in research aimed at exploring the protective effects of a ketogenic diet on the complications of diabetes.

“The Impact Circle is one of the most exciting and rewarding programs at the Buck,” says President and CEO, Eric Verdin, MD. “It brings donors close to the scientists they support and it provides invaluable start-up funds for early stage research projects.”

Here’s how the program works: Each year Impact Circle members are presented with a number of projects that focus on “dream big” research projects – collaborative efforts between Buck labs that are not far enough along to qualify for government funding. Faculty “pitch” their projects to the Impact Circle, and members vote on which project to support. A $5,000 donation guarantees one vote and is the entry point for the Impact Circle; this year a Buck Trustee, who wishes to remain anonymous, matched contributions from new members who joined prior to final voting, enabling the group to hit an all-time high in support.

“My wife and I so enjoy being part of the Impact Circle,” said Dayton Coles – he and his wife Sheri are long-time members of the group. “We get to know the scientists and it’s a thrill to be able to make a difference in their work.” Past Impact Circle projects have led to successful applications for federal funding and have resulted in high impact publications. “There’s great comradery in the group and it’s one of the best ways to keep on top of the latest research,” he said.

This year’s project could lead to new therapeutics

This year’s Impact Circle project is a joint venture between the Kapahi and Verdin labs, focusing on the complications of type 2 diabetes. The work could lead to new therapeutics for conditions including cardiomyopathy, neuropathy, chronic kidney disease and Alzheimer’s.

The science is aimed at AGEs (advanced glycation end products). AGEs are toxic molecules that form when the reactive by-products of sugar metabolism attach themselves to proteins and DNA.  AGEs affect nearly every cell type and are a normal byproduct of metabolism – they are not usually a problem for those who eat a healthy diet. As might be expected, AGEs are a real issue when blood sugar levels are chronically elevated, as in diabetes. The increase of AGEs may explain why diabetes is one of the biggest risk factors for Parkinson’s and Alzheimer’s disease.  And it doesn’t help that AGEs accumulate with aging.

A perfect collaboration

The project is a perfect marriage between the two labs. Working in simple animals, the Kapahi lab has developed unique expertise in AGEs, and the Verdin lab has special know-how in mouse metabolism.  “We are very excited to move our basic research in worms and flies into mice,” said Buck faculty Pankaj Kapahi, Ph.D. “We are very grateful to the Impact Circle for backing a project that will provide evidence to support clinical trials of metabolic interventions to prevent or maybe even reverse diabetic complications.”  Scientists in the Kapahi lab showed that enhancing fat metabolism reduced AGEs, reduced neurodegeneration and extended lifespan in the simple animals. Significantly, researchers identified the cellular pathway involved in both sensing and repairing AGEs.

The Verdin lab brings its experience studying ketogenic diets to the project.  Ketogenic diets are extremely low in carbohydrates and high in fats – in mice they shift metabolism from sugar to fat. The Verdin lab has already observed that a ketogenic diet extends lifespan and preserves cognitive function as mice age – this project will take it to the next step. “The Impact Circle support will allow us to understand why a ketogenic diet works,” said project co-leader John Newman, MD, PhD.  “We’ll be able to measure the accumulation and clearing of AGEs and identify molecular targets for drug discovery that could prevent dementia in both diabetics and non-diabetics. This work in mammals is an essential step on the way to the clinic.”

The skinny on ketogenic diets

Low carbohydrate, high fat ketogenic diets promote the formation of ketone bodies which are created in the liver and pass into the brain, replacing glucose as an energy source. The ketogenic diet is currently used to control epileptic seizures in children. Its neuroprotective effects in mice have piqued the interest of some consumers who want to get a leg up on maintaining brain health.

But ketogenic diets are hard to follow and maintain; this project may help provide some help in that area.  Newman, who is also a practicing geriatrician at the San Francisco VA Medical Center, will test compounds that promote ketone body production in both diabetic mice and normal aging mice.  “We want to see if these drugs or ketone body compounds act as signals that turn on fat metabolism and clean AGEs. Maybe the treatments will be sufficient to provide protection so that going on a stringent diet won’t be necessary,” he said.

In the meantime, avoid AGEs! 

Both Kapahi and Newman say keeping blood sugar at a healthy levels will go a long way to protect against production of toxic AGEs.  But both warn that AGEs can also be consumed directly in the food we eat.  Charred meat is loaded with AGEs – as is almost any food that has been fried or heated to a high temperature.  (John Newman aptly compares AGEs to soot left from a wood burning fire.) Unfortunately, AGEs taste good, making them hard to resist. Kapahi says it’s a dilemma for both humans and for those simple animals.  “When we give worms options to either eat their regular food or AGEs, they always go for the AGEs.” he said.

Friedman’s Home Improvement and Sonoma Raceway 4th annual STEM Race Car Challenge

More than 1,900 North Bay students from 33 schools and clubs will take part in the 4th annual STEM Race Car Challenge, presented by Friedman’s Home Improvement. This curriculum-based event, which is a partnership with Sonoma Raceway, Kid Scoop News and Friedman’s Home Improvement, focuses on educating students about the importance of science, technology, engineering and mathematics (STEM).

Groups of student engineers from 33 North Bay elementary schools and youth groups, a record level of participation for the program, will be tasked with developing a gravity-powered race car utilizing recycled materials. Kid Scoop News has worked closely with teachers to develop a STEM-based curriculum that challenges students to think critically and work collaboratively to build the quickest car. Activities in the STEM Race Car Challenge, presented by Friedman’s Home Improvement are designed to introduce and reinforce both national common core standards and 21st century job skills.

Students will put their purpose-built race cars to the test in a series of qualifying rounds at each school, which will narrow down to a group of students who will compete in the final round on Saturday, June 24, of the Toyota/Save Mart 350 weekend. The winning student engineers of the STEM Race Car Challenge will serve as VIPs during the Carneros 200 NASCAR West Series race on Saturday, receive a trophy and tickets to Sunday’s Toyota/Save Mart 350 race, courtesy of Friedman’s Home Improvement.

Sonoma Raceway has partnered with Sonoma-based Kid Scoop News, a children’s literacy non-profit that publishes and distributes a free monthly reader to 500 classrooms and 18,000 kids in the North and East Bay, on the race car challenge. Kid Scoop News has been key to the program, as the organization is a leader in providing high-interest content that motivates kids to read and explore topics, including STEM. Through their effort, the number of participating schools has nearly tripled from 12 schools in 2016 to 33 schools in 2017.

North Bay schools and clubs participating in this year’s STEM Race Car Challenge include:

  • Boys and Girls Clubs of Central Sonoma County: Camp East Santa Rosa; Camp North Santa Rosa; Camp Roseland; Camp Windsor; Camp Cloverdale; Camp Guerneville; Camp Healdsburg and Camp Rohnert Park
  • Boys and Girls Clubs of Sonoma Valley: Sassarini Elementary School; El Verano Elementary School; Altimira Middle School; Flowery Elementary School and Dunbar Elementary School.
  • Coleman Elementary School (San Rafael)
  • Dunbar Elementary School (Sonoma)
  • El Verano Elementary School (Sonoma)
  • Flowery Elementary School (Sonoma)
  • Hidden Valley School (Santa Rosa)
  • Jefferson Elementary School (Cloverdale)
  • La Tercera Elementary School (Petaluma)
  • Loma Verde Elementary (Petaluma)
  • Lynwood Elementary (Novato)
  • Marguerite Hahn School (Rohnert Park)
  • Meadow Elementary (Petaluma)
  • Napa Junction Elementary School (American Canyon)
  • Prestwood Elementary School (Sonoma)
  • Sassarini Elementary School (Sonoma)
  • Sheppard Elementary School (Santa Rosa)
  • University Elementary (Rohnert Park)
  • Waldo Rohnert Elementary (Rohnert Park)
  • Washington School (Cloverdale)
  • West Side Elementary School (Healdsburg)

“The unique thing about STEM activities is that the students are able to connect the challenge of building a race car to the real world at Sonoma Raceway,” said Vicki Whiting, content developer and publisher of Kid Scoop News. “While the students are having fun with race cars, it is reinforcing their core STEM curriculum.”

NASCAR fans and guests are invited to watch the finals of the STEM Race Car Challenge, presented by Friedman’s Home Improvement at 10 a.m. on Saturday, June 24, in Sonoma Raceway’s Sunoco Victory Lane located just south of the main grandstand. For tickets or more information on NASCAR’s annual visit to Sonoma, visit or call 800-870-RACE.

Midstate Construction Completes Camphora Apartments

Camphora Apartments

May 2017

Owner Eden Housing and general contractor Midstate Construction Corporation recently completed Camphora Apartments in Soledad, CA.

Designed by KTGY Architecture + Planning of Oakland, this project includes demolition of existing site and new construction of a 44 unit, two story, wood framed affordable housing community.

This project began with the complete demolition of existing farmworker housing built in 1960. Site renovations include onsite well and storage facility fire pump, photovoltaic panels, freeway sound wall, built-in BBQ areas, play areas, low water landscaping with drip under sod.

A new sewer system with lift station was created and tunneled below U.S. Route 101 and a Union Pacific Railroad line to tie into a City of Soledad force main that serves the state prison. Work was successfully coordinated with the correctional facility to tie into the sewer force mains without affecting their inhabitants.

Each unit has independent climate control via attached heat pumps. Each unit receives hot water via a local insta-hot water heaters. Combined with ubiquitous photovoltaic panels, onsite well and sewer, residents experience very low monthly utility bills. Vestuvių planavimas MOOD Weddings

Camphora was certified as LEED AP Homes Platinum.

Like Camphora Apartments - May 2017 on Facebook share on Twitter

Sonoma Raceway Hosts Pacific Gas and Electric Military Career Day

What do the military and NASCAR have in common?

Military careers, military lifestyle, and NASCAR are all about high performance. Military candidates and military spouses have the core competencies and values employers need for their best performance. The transition from military to civilian life is still not always easy, so Sentinels of Freedom – a nationwide 501(c)(3) nonprofit – works to ease the process for severely wounded and injured veterans as they pursue higher education and find career-focused employment. Many companies need diverse candidates who are agile leaders with mechanical, technical, and processing skills – qualities that veterans possess and can contribute to the workplace.

Job Seeker Registration

Click Here for Job Seeker Registration

Job Employer Registration

Click Here for Job Employer Registration


To highlight PG&E’s 1,000 Careers Project and its commitment to hire 1,000 veterans by 2023, PG&E has joined forces with Sentinels of Freedom and Sonoma Raceway to invite you to participate in the 3rd annual Military Career Day event. The day will feature workshops, panel presentations and a job fair. The event will focus on translating the skill sets for military members transitioning to the job market, and will include information on non-traditional careers for disabled veterans.


Open to all active, guard, reserve, veterans and military spouses.


Sonoma Raceway, 29355 Arnold Dr., Sonoma, CA


Friday, June 23, 2017

10am – 11:50am – Job Fair & Workshop

Noon – 12:20pm – Jesse Iwuji Q&A (NASCAR driver and active duty Lieutenant in the US Navy serving as a Surface Warfare Officer)

12:30 – 1:00pm – Leadership Panel

This event will take place as part of the Toyota/Save Mart 350 Monster Energy NASCAR Cup Series event weekend at Sonoma Raceway.

For questions please email: